# Aurobindo Pharma Limited - Inspection Records

Source: https://www.keypedia.com/companies/aurobindo-pharma-limited/9bedb5d4-0483-4173-bc76-1c5737a28fc1

> Inspection records and compliance data for Aurobindo Pharma Limited in Bachupally, None. Access full analysis and detailed observations.

---

## Details

- Name: Aurobindo Pharma Limited
- FEI Number: 3004446312
- City: Bachupally
- State: None
- Country Name: India
- Address Line 1: 314 Medchal - - Malkajgiri District, Unit 12; Survey No
- Zip Code: None
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE

## Related Documents

- [483 - Aurobindo Pharma Limited - 2025-09-05](https://www.keypedia.com/records/483/aurobindo-pharma-limited/31ac5498-c32b-4f35-b9ad-a996d6e6c456) — source: FDA, date: September 5, 2025
- [FDA Inspection 1286862 - Aurobindo Pharma Limited - 2025-09-05](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/e27c7a63-48f1-4316-8130-b5019c93f3db) — source: FDA, date: September 5, 2025
- [FDA Inspection 1286862 - Aurobindo Pharma Limited - 2025-09-05](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/bad39678-8eb7-42c7-b820-7b3bab50ca4f) — classification: Official Action Indicated (OAI), source: FDA, date: September 5, 2025
- [FDA Inspection 1241780 - Aurobindo Pharma Limited - 2023-03-09](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/11833527-0353-45ec-967e-1b9b8ade4fdf) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 9, 2023
- [483 - Aurobindo Pharma Limited - 2020-02-21](https://www.keypedia.com/records/483/aurobindo-pharma-limited/892c968e-c743-4108-bf0a-b6616316dc36) — source: FDA, date: February 21, 2020
- [FDA Inspection 1118385 - Aurobindo Pharma Limited - 2020-02-21](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/6c77bf62-e7b5-45b7-ad26-a5543e122130) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 21, 2020
- [FDA Inspection 1118385 - Aurobindo Pharma Limited - 2020-02-21](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/c9b52e8f-bf77-492c-8a49-f01a2f3d34e0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 21, 2020
- [483 - Aurobindo Pharma Limited - 2020-02-17](https://www.keypedia.com/records/483/aurobindo-pharma-limited/733cada2-a1ca-47e0-b637-93e8c8b28dd8) — source: FDA, date: February 17, 2020
- [FDA Inspection 1046218 - Aurobindo Pharma Limited - 2018-03-16](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/d4cc3587-20be-4443-8712-6e49c304278b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 16, 2018
- [FDA Inspection 1046218 - Aurobindo Pharma Limited - 2018-03-16](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/5d8760ef-fede-4b1f-82af-36c3aecf92c5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 16, 2018
- [FDA Inspection 847151 - Aurobindo Pharma Limited - 2013-08-16](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/43183e2b-7f58-44fb-9134-fdbca5710164) — classification: No Action Indicated (NAI), source: FDA, date: August 16, 2013
- [FDA Inspection 847151 - Aurobindo Pharma Limited - 2013-08-16](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/76f16784-f959-4467-baf8-dd96ecc6fb14) — classification: No Action Indicated (NAI), source: FDA, date: August 16, 2013
- [FDA Inspection 793023 - Aurobindo Pharma Limited - 2012-06-26](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/de49d5a6-4b83-440a-9703-ee48be6d0a2c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 26, 2012

## Related Companies

- [Shire Human Genetic Therapies, Inc.](https://www.keypedia.com/companies/shire-human-genetic-therapies-inc/7051823d-8cc7-4d72-8a82-a0de9bbb9497)
- [Apotek Production & Laboratorier AB](https://www.keypedia.com/companies/apotek-production-laboratorier-ab/79450c29-5eaa-4d9d-9707-c70f5ba3598f)
- [Playtex Manufacturing, Inc. - Plant #2](https://www.keypedia.com/companies/playtex-manufacturing-inc-plant-2/84ec69a6-5886-459c-b12a-e1e20a549c4f)
- [Biokosmes Srl](https://www.keypedia.com/companies/biokosmes-srl/61d3caa9-0547-4e76-b676-0479362fa9a3)
- [Kinkando Co., Ltd.](https://www.keypedia.com/companies/kinkando-co-ltd/34ba9ef0-18a3-46b9-a5fe-ad6ed9632ef0)
- [Murty Pharmaceuticals, Inc](https://www.keypedia.com/companies/murty-pharmaceuticals-inc/8d7f8024-f6fd-463e-b94f-63cd3b745e96)
- [MW Encap Ltd.(NextPharma Edinburgh)](https://www.keypedia.com/companies/mw-encap-ltdnextpharma-edinburgh/e8cf1af5-d17a-4c79-ba7d-498a371fbc50)
- [Cosmo S.p.A.](https://www.keypedia.com/companies/cosmo-spa/986e07cc-bedf-42e7-859e-91b78e08ba75)
- [Tedor Pharma, Inc.](https://www.keypedia.com/companies/tedor-pharma-inc/a9fa17c4-23c1-4bcf-ad03-bb9635bb063d)
- [Catalent Argentina S.A.I.C.](https://www.keypedia.com/companies/catalent-argentina-saic/c4e097df-85fe-4836-9778-b395fe1e78de)

## Related Officers

- [Xiaohong Lu](https://www.keypedia.com/people/xiaohong-lu/c090ea51-c732-4d96-8063-30a8f2eb21ba)
- [Advisor](https://www.keypedia.com/people/frederick-razzaghi/7346f6ec-1d9a-4ad3-abde-0497dcd9c8b5)
- [Eileen A. Liu](https://www.keypedia.com/people/eileen-a-liu/fa051db4-1242-4181-9af9-5b3cd2de5689)
- [Joseph A. Piechocki](https://www.keypedia.com/people/joseph-a-piechocki/1977a57b-4976-4b01-b8da-66a84b26e803)